Skip To Content

News & Events

Given the activity level of our attorneys, we are confident in showcasing the various matters that our clients have given us the privilege to work on and approved to post here.

Posts

  • November 29 2023

    Client Alert: New Regulations Affecting New York City Employers’ Obligation to Provide Paid Time Off

    The New York City Department of Consumer and Worker Protection recently issued amendments to the rules implementing New York City’s Earned Safe and Sick Time Act (“ESSTA”).

    Click here to read the alert.

  • November 28 2023

    Fortress Biotech, Inc. announced the closing of its Public Offering in the amount of $10,00,000. EG&S acted as counsel to the Placement Agent.

  • November 28 2023

    Veea Inc., a digital transformation company, and Plum Acquisition Corp. I, a Cayman Islands exempted company formed as a special purpose acquisition company, announced their entry into a definitive business combination agreement related to a proposed merger expected to result in Veea becoming a publicly traded company whose business, after the closing, assuming the occurrence thereof, will be the continued business of Veea.  EGS acted as counsel to Veea Inc.

  • November 28 2023

    Client Alert: New Laws Prohibit Certain Provisions in Release Agreements and Increase the Statute of Limitations for Certain Claims of Discrimination, Harassment, and Retaliation

    On November 17, 2023, New York Governor Kathy Hochul signed into law a bill amending the New York law governing settlement agreements between employers and employees resolving claims of harassment, discrimination and retaliation.  The amendment prohibits including certain terms in such agreements.

    Click here to read the alert.

  • November 21 2023

    Ontrak, Inc. announced the closing of its Public Offering in the amount of $6,300,000. EG&S acted as counsel to the Placement Agent.

  • November 19 2023

    Avenue Therapeutics, Inc. announced the closing of its Public Offering in the amount of $5,000,000. EG&S acted as counsel to the Placement Agent.

  • November 18 2023

    Reviva Pharmaceuticals Holdings, Inc. announced the closing of its Registered Direct offering in the amount of $30,000,000. EG&S acted as counsel to the Placement Agent.

  • November 17 2023

    Client Alert: NLRB Publishes Final Rule Broadening the Joint-Employer Standard-Effective Date Extended to February 26, 2024

    On October 27, 2023, the National Labor Relations Board (“NLRB” or “Board”) published a final rule expanding the standard used to determine Joint-Employer Status under the National Labor Relations Act (“NLRA”). The final rule establishes that, under the NLRA, two or more entities may be considered joint employers of a group of employees if each entity has an employment relationship with the employees, and if the entities share or codetermine one or more of the employees’ essential terms and conditions of employment.

    Click here to read the alert.

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”